Summit Asset Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-2,070
| Closed | -$252K | – | 155 |
|
|
2023
Q2 | $252K | Hold |
2,070
| – | – | 0.07% | 134 |
|
|
2023
Q1 | $318K | Hold |
2,070
| – | – | 0.09% | 113 |
|
|
2022
Q4 | $372K | Hold |
2,070
| – | – | 0.11% | 103 |
|
|
2022
Q3 | $245K | Hold |
2,070
| – | – | 0.08% | 128 |
|
|
2022
Q2 | $296K | Buy |
2,070
+2
| +0.1% | +$286 | 0.09% | 119 |
|
|
2022
Q1 | $356K | Buy |
2,068
+205
| +11% | +$35.3K | 0.1% | 112 |
|
|
2021
Q4 | $473K | Sell |
1,863
-868
| -32% | -$220K | 0.13% | 94 |
|
|
2021
Q3 | $1.05M | Buy |
2,731
+940
| +52% | +$362K | 0.33% | 41 |
|
|
2021
Q2 | $421K | Buy |
1,791
+220
| +14% | +$51.7K | 0.13% | 92 |
|
|
2021
Q1 | $206K | Buy |
+1,571
| New | +$206K | 0.07% | 142 |
|
|
2020
Q4 | – | Sell |
-3,174
| Closed | -$225K | – | 137 |
|
|
2020
Q3 | $225K | Buy |
+3,174
| New | +$225K | 0.09% | 118 |
|